Vit C: Clinical Trials

5 trials of Vit C, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated, 1 completed, 1 recruiting. 5 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Terminated 3, Completed 1, Recruiting 1
Phase 31Completed 1

Follow Vit C: new trials by email Literature Review of Vit C trials Research Report on Vit C

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effectiveness of Vitamin C Supplementation in Treatment of Rickets
Vit C - Nutritional Rickets, Bone Turnover Rate Disorder
Phase 2 / Phase 3CompletedCairo University882022-03-012023-03-08
Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
Ascorbic Acid, Carboplatin, Cisplatin - Clonal Cytopenia of Undetermined Significance, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
Phase 2RecruitingMayo Clinic802018-03-232026-09-28
Pazopanib Hydrochloride With or Without Ascorbic Acid in Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed by Surgery
Ascorbic Acid, Pazopanib Hydrochloride - Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma
Phase 2TerminatedAcademic and Community Cancer Research United52018-02-162022-03-31
Docetaxel With or Without Ascorbic Acid in Treating Patients With Metastatic Prostate Cancer
Ascorbic Acid, Docetaxel, Laboratory Biomarker Analysis - Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma
Phase 2TerminatedSidney Kimmel Comprehensive Cancer Center at Johns Hopkins502016-06-202023-06-07
High Dose Vitamin C in the Critically Ill Patient
Ascorbic Acid, Ringers Lactate or Normal Saline - Shock
Phase 2TerminatedRutgers, The State University of New Jersey112013-02-012017-05-11

Conditions studied

Carcinoma, Renal Cell (1)  ·  Clear-cell metastatic renal cell carcinoma (1)  ·  Hodgkin Disease (1)  ·  Hypovolemia (1)  ·  Leukemia, Myelomonocytic, Chronic (1)  ·  Lymphoma (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Prostatic Neoplasms (1)  ·  Rickets (1)  ·  Shock (1)  ·  Vitamin D Deficiency (1)

Sponsors

Academic and Community Cancer Research United (1)  ·  Cairo University (1)  ·  Mayo Clinic (1)  ·  Rutgers, The State University of New Jersey (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)

Countries

United States (4)  ·  Egypt (1)

Top investigators

Channing Paller, MD (1)  ·  Fatina Fadel, Prof (1)  ·  Lance C Pagliaro (1)  ·  Thomas E Witzig, M.D. (1)  ·  Vicente Gracias, MD (1)

Results publications

PMID 39076107, PMID 39352751

NIH funding

P30CA006973 (1), P30CA015083 (1), P50CA097274 (1)